Urea

Urea

SCHEMBL6754151

NC(N)=O.Nc1cccc2c1CCCC2=O

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 3/20 0.48
PARP1 P09874 2/20 0.47
MAOA P21397 2/20 0.43
MAOB P27338 2/20 0.43
MRGPRX4 Q96LA9 1/20 0.43
CYP2A6 P11509 1/20 0.43
FGFR1 P11362 1/20 0.38
FGFR2 P21802 1/20 0.38
FGFR4 P22455 1/20 0.38
FGFR3 P22607 1/20 0.38
ADRB2 P07550 1/20 0.38
ADRB1 P08588 1/20 0.38
HTR1A P08908 1/20 0.38
ADRB3 P13945 1/20 0.38
TSHR P16473 1/20 0.38
SLC6A4 P31645 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
PRKCI P41743 1/20 0.35
TYMS P04818 1/20 0.35
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2768935 0.93 PARP1 (0.53) BRD4PARP1MAOAMAOBMRGPRX4
Formamide SCHEMBL6754148 0.86 PARP1 (0.47) BRD4PARP1MAOAMAOBMRGPRX4
SCHEMBL2480404 0.81 PARP1 (0.56) BRD4PARP1MAOAMAOBCYP2A6
SCHEMBL30853881 0.81 BRD4 (0.52) BRD4PARP1MAOAMAOBMRGPRX4
SCHEMBL6808475 0.76 BRD4 (0.45) BRD4PARP1MAOAMAOBMRGPRX4
SCHEMBL7555603 0.75 BRD4 (0.42) BRD4PARP1ADRB2ADRB1ADRB3
SCHEMBL1759573 0.75 MRGPRX4 (0.51) BRD4MAOAMAOBMRGPRX4CYP2A6
Hydrochloric Acid SCHEMBL6811509 0.75 BRD4 (0.44) BRD4PARP1MAOAMAOBMRGPRX4
SCHEMBL388480 0.74 PARP1 (0.53) BRD4PARP1MAOAMAOBMRGPRX4
SCHEMBL21772776 0.73 PARP1 (0.51) BRD4PARP1MAOAMAOBMRGPRX4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6706924-B2 INCLUDES A STEP IN WHICH ORTHO-NITROTOLUENE IS REACTED WITH ONE OR MORE ACRYLIC ACID DERIVATIVES SUCH AS ACRYLONITRILE BAYER AKTIENGESELLSCHAFT (DE) 2004-03-16 US claimed
US-20020103401-A1 Process for the production of 1,5-naphthalenediamine BAYER AKTIENGESELLSCHAFT (DE) 2002-08-01 US claimed
US-6706924-B2 INCLUDES A STEP IN WHICH ORTHO-NITROTOLUENE IS REACTED WITH ONE OR MORE ACRYLIC ACID DERIVATIVES SUCH AS ACRYLONITRILE BAYER AKTIENGESELLSCHAFT (DE) 2004-03-16 US disclosed
US-20020103401-A1 Process for the production of 1,5-naphthalenediamine BAYER AKTIENGESELLSCHAFT (DE) 2002-08-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020103401-A1 Process for the production of 1,5-naphthalenediamine BBOX1, CYP4B1, NAT1 BRD4 165/4885PARP1 1388/4885MAOA 826/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.